1. Biedenkopf, N., Lange-Grünweller, K., Schulte, F. W., Weißer, A., Müller, C., Becker, D., Becker, S., Hartmann & Grünweller, A. The natural compound silvestrol is a potent inhibitor of Ebola virus replication. Antiviral Research 2017, 137, 76-81.
  2. Baumann, B. F., Bohnenstengel, D., Siegmund, H., Wajant, C., Weber, I., Herr, K.M., Debatin, P. Proksch, P. and Wirth, T. Rocaglamide derivatives are potent inhibitors of NF-_B activation in T-cells. J. Biol. Chem. 2002, 277: 44791–44800.
  3. Bohnenstengel, F.I., Steube, K.G., Meyer, C., Nugroho, B.W., Hung, P.D., Kiet, L.C. and Proksch P. Structure activity relationships of antiproliferative rocaglamide derivatives from Aglaia species (Meliaceae). Z Naturforsch [C] 1999, 54: 55-6.
  4. Bordeleau M.E., Robert, F., Gerard, B., Lindqvist, L., Chen, S.M-H., Wendel, H.G., Brem, B., Greger, H., Lowe, S.W., Porco, J.A. and Pelletier, J. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Inv. 2008, 118: 1–11.
  5. Christensen, H. 2002. Ethnobotany of the Iban and the Kelabit. Joint Publication of Forest Department Sarawak, NEPCon and University of Aarhus. Videbaek, Denmark.
  6. El Sous, M., Khoo, M.L., Holloway, G., Owen, D., Scammells, P.J. and Rizzacasa, M.A. Total synthesis of (-)-episilvestrol and (-)-silvestrol. Angew Chem Int Ed Engl. 2007, 46(41):7835-8.
  7. Fahrig, T., Gerlach, I. and Horvath, E. 2005. A synthetic derivative of the natural product rocaglaol is a potent inhibitor of cytokine mediated signaling and shows neuroprotective activity in vitro and in animal models of Parkinson's disease and traumatic brain injury. Mol Pharmacol. 2007, 67: 1544-1555.
  8. Gerard, B., Cencic, R., Pelletier, J. and Porco, J.A .Jr. Enantioselective synthesis of the complex rocaglate (-)-silvestrol. Angew Chem Int Ed Engl. 2009, 46(41):7831-4.
  9. Hwang, B.Y., Su, B.N., Chai, H., Mi, Q., Kardono, L.B., Afriastini, J.J., Riswan, S., Santarsiero, B.D., Mesecar, A.D., Wild, R., Fairchild, C.R., Vite, G.D., Rose, W.C., Farnsworth, N.R., Cordell, G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem. 2004, 69: 3350-3358.
  10. Hwang, B.Y., Su, B.N., Chai, H., Mi, Q., Kardono, L.B., Afriastini, J.J., Riswan, S., Santarsiero, B.D., Mesecar, A.D., Wild, R., Fairchild, C.R., Vite, G.D., Rose, W.C., Farnsworth, N.R., Cordell, G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D. Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris. J Org Chem. 2004, 69:6156. (erratum)
  11. King, M.L., Chiang, C.C., Ling, H.C., Fujita, E., Ochiai, M. and McPhail, A.T., X-ray crystal structure of rocaglamide, a novel antileukemic 1H-cyclopenta[b]benzofuran from Aglaia elliptifolia. J Chem Soc, Chem Comm. 1982, 1150-1151.
  12. Kim, S., Hwang, B.Y., Su, B., Chai, H., Mi, Q., Kinghorn, A.D., Wild, R., Swanson, S.M., Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or 7. Anticancer Research. 27(4B): 2175-2183.
  13. Lucas, D.M., Edwards, R.B., Lozanski, G., West, D.A., Shin, J.D., Vargo, M.A., Davis, M.E., Rozewski, D.M., Johnson, A.J., Su, B.N., Goettl, V.M., Heerema, N.A., Lin, T.S., Lehman, A., Zhang, X., Jarjoura, D., Newman, D.J., Byrd, J.C. and Kinghorn, A.D., Grever, M.R., 2009. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood 113(19): 4656-4666.
  14. Mi,Q., Kim, S., Hwang, B.Y., Hwang, B.A., Su, B., Chai, H., Arbieva, Z.H., Kinghorn, A.G. and Swanson, S., 2006. Silvestrol regulates G2/M checkpoint genes independent of p53 activity. Anticancer Res. 26:3349-3356.
  15. Meurer-Grimes, B.M., Yu, J. and Viaro, G.L., 2004. Therapeutic compounds and methods. US Patent 6,710,075B2.
  16. Proksch, P., Edrada, R., Ebel, R., Bohnenstengel, F.I.,and Nugroho, B.W., 2001. Chemistry and biological activity of rocaglamide derivatives and related compounds in Aglaia species (Meliaceae). Curr Org Chem 5: 923- 938.
  17. Proksch, P., Giaisi, M., Treiber, M.K., Palfi, K., Merling, A., Spring, H., Krammer, P.H. and Li-Weber, M., 2005. Rocaglamide derivatives are immunosuppressive phytochemicals that target NF-AT activity in T cells. J Immunol 174: 7075-7084.
  18. Rivero-Cruz, J.F., Chai, H.B., Kardono, L.B., Setyowati, F.M., Afriatini, J.J., Riswan, S., Farnsworth, N.R., Cordell,G.A., Pezzuto, J.M., Swanson, S.M. and Kinghorn, A.D., 2004. Cytotoxic constituents of the twigs and leaves of Aglaia rubiginosa. J. Nat. Prod. 67(3), 343-347.
  19. Salim, A.A., Chai, H., Rachman, I., Riswan, S., Kardono, L.b.s., Farnsworth, N.R., Carcache-Blanco, E.J., Kinghorn, A.D., 2007. Constituents of the leaves and stem bark of Aglaia foveolata. Tetrahedron 63(33): 7926-7934.
  20. Soepadmo, E., (Ed.), 2007. Tree flora of Sabah and Sarawak (vol. 6) Malaysia, Ampang Press Sdn. Bhd.